Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Follia

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|April 3, 2021
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerClaudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, et al.
BMC Bioinformatics|December 14, 2020
Computational modeling of the immune response in multiple sclerosis using epimod frameworkSimone Pernice, Laura Follia, Alessandro Maglione, et al.
Cancers|April 5, 2020
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer PatientsGiorgia Mandili, Laura Follia, Giulio Ferrero, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccinationGiorgia Mandili, Claudia Curcio, Sara Bulfamante, et al.
Frontiers in Oncology|March 16, 2019
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic BiomarkersLaura Follia, Giulio Ferrero, Giorgia Mandili, et al.
Molecular Medicine (Cambridge, Mass.)|January 19, 2024
Small noncoding RNAs and sperm nuclear basic proteins reflect the environmental impact on germ cellsGiulio Ferrero, Rosaria Festa, Laura Follia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|April 3, 2021
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerClaudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, et al.
BMC Bioinformatics|December 14, 2020
Computational modeling of the immune response in multiple sclerosis using epimod frameworkSimone Pernice, Laura Follia, Alessandro Maglione, et al.
Cancers|April 5, 2020
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer PatientsGiorgia Mandili, Laura Follia, Giulio Ferrero, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccinationGiorgia Mandili, Claudia Curcio, Sara Bulfamante, et al.
Frontiers in Oncology|March 16, 2019
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic BiomarkersLaura Follia, Giulio Ferrero, Giorgia Mandili, et al.
Molecular Medicine (Cambridge, Mass.)|January 19, 2024
Small noncoding RNAs and sperm nuclear basic proteins reflect the environmental impact on germ cellsGiulio Ferrero, Rosaria Festa, Laura Follia, et al.
Pageof 1